Erroneous administration of vinblastine
- 76 Downloads
This case describes a series of errors which resulted in an avoidable death of the patient. Upon being presented with the 83-year-old patient and her complaints, the physician in charge attempted to prescribe Vasolastine® (a complex preparation used, for example, in treatment of angiopathy, which is administered intramuscularly once a day). Unfortunately he misspelled the name of the medicine as Vinplastyna—a non-existent preparation. When the patient’s daughter went to collect the prescription from the pharmacist she was dispensed Vinblastin (vinblastine—a cytostatic medicine used, for example, in treating Hodgkin’s disease, non-Hodgkin’s lymphoma, chronic lymphatic leukemia and testicular cancer). The visiting community nurses administered a dose of this medicine on seven consecutive days. Upon being given the seventh dose, the patient displayed symptoms of myelophthisis, and was admitted to an Intensive Care Ward, where despite the treatment, she died.
KeywordsIllegible prescription Legibility Medication error Myelophthisis Vinblastine
- 6.Act of June 6, 1997 Penal Code (Journal of Laws of 1997, No 88, item 553); Poland.Google Scholar
- 7.Act of September, 2001 Pharmaceutical Law (Journal of Laws of 2001, No 126, item 1381); Poland.Google Scholar
- 8.Regulation of the Minister of Health of October 18, 2002 on dispensing medicinal products and medical goods from pharmacies (Journal of Laws of 2002, No 183, item 153); Poland.Google Scholar
- 9.Act of July 5, 1996 on the Profession of Nurse and Midwife (Journal of Laws of 1996, No 91, item 410); Poland.Google Scholar